Markets

Company News For Dec 12, 2017

  • Shares of KMG Chemicals, Inc. KMG gained 0.3% after reporting first quarter 2018 earnings of $0.83 a share, surpassing the Zacks Consensus Estimate of $0.63
  • Shares of argenx SE ARGX rallied almost 79% after the company reported positive results from Phase 2 proof-of-concept trial of its drug ARGX-113 used in the treatment of generalized myasthenia gravis
  • Blueprint Medicines Corporation's BPMC shares rallied 22.9% after the company reported positive new data from Phase 1 clinical trial of its drug Avapritinib
  • bluebird bio, Inc.'s BLUE shares surged 17.9% after reporting positive clinical results from Phase 1 multicenter study of LentiGlobin gene therapy used to cure sickle cell disease at the ASH2017

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

KMG Chemicals, Inc. (KMG): Free Stock Analysis Report

bluebird bio, Inc. (BLUE): Free Stock Analysis Report

Blueprint Medicines Corporation (BPMC): Free Stock Analysis Report

ARGENX SE-ADR (ARGX): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BLUE BPMC ARGX

Other Topics

Investing Stocks